Business

MediBuddy raises $18 mn for strategic acquisitions, continued expansion

In February 2022, MediBuddy raised $125 million during the Series C funding.

New Delhi: Digital healthcare platform MediBuddy on Wednesday said it has secured additional funding of $18 million from existing investors Quadria Capital, Lightrock and TEAMFund.

In February 2022, MediBuddy raised $125 million during the Series C funding.

The additional funding, said the company, will put it in a solid position to navigate the current landscape and achieve its ambitious growth targets over the next three years, driving strategic acquisitions and continued expansion.

“MediBuddy’s growth trajectory has consistently achieved a Compound Annual Growth Rate (CAGR) of 95.5 per cent over the past three years. The additional funds will be critical in driving our strategic acquisition initiatives, further expanding our reach, and enhancing the depth and breadth of our services,” said Satish Kannan, Co-Founder and CEO of MediBuddy.

Two of MediBuddy’s recent strategic acquisitions, such as Clinix, an online medical consultation platform focusing on rural India, and US-based Aetna Inc’s vHealth by Aetna business (Indian Health Organization Pvt Ltd), have further amplified its presence in the healthcare domain.

MediBuddy currently helps more than 35,000 users every day. It currently has an existing customer base of more than 3 crore and offers services in 16 Indian languages.

“As a participant in this funding round, we envisage MediBuddy to consolidate its market dominance and create significant value for its customers in the next chapter of its evolution,” said Sunil Thakur, Partner, Quadria Capital.

This post was last modified on August 30, 2023 8:22 pm

Share
Indo-Asian News Service

Indo-Asian News Service or IANS is a private Indian news agency. It was founded in 1986 by Indian American publisher Gopal Raju as the "India Abroad News Service" and later renamed. The service reports news, views and analysis from the subcontinent about the country, across a wide range of subjects.

Load more...